Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma

被引:0
|
作者
Jiang, J. [1 ]
Berry, M. F. [1 ]
Lui, N. S. [1 ]
Liou, D. Z. [1 ]
Trope, W. L. [1 ]
Backhus, L. M. [1 ]
Shrager, J. B. [1 ]
机构
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
关键词
multifocal lung adenocarcinoma; EGFR; KRAS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP06.03-06
引用
收藏
页码:S484 / S485
页数:2
相关论文
共 50 条
  • [1] Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma
    Jiang, Jiahao
    Berry, Mark F.
    Lui, Natalie S.
    Liou, Douglas Z.
    Trope, Winston L.
    Backhus, Leah M.
    Shrager, Joseph B.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (06)
  • [2] Heterogeneity of the EGFR / KRAS Gene Mutation in Multifocal Lung Adenocarcinoma and the Clinical Significance
    Li, Lin
    Zhang, Susu
    Dai, Hongshuang
    Ying, Jianming
    Gao, Yanning
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S511 - S512
  • [3] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    [J]. BMC Proceedings, 4 (Suppl 2)
  • [4] EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
    Chalela, Roberto
    Gonzalez-Garcia, Jose Gregorio
    Khilzi, Karys
    Curull, Victor
    Sanchez-Font, Albert
    Longaron, Raquel
    Rodrigo-Calvo, Maria Teresa
    Martin-Ontiyuelo, Clara
    Gea, Joaquim
    Bellosillo, Beatriz
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [5] Prognostic Impact of EGFR and KRAS Mutations in Patients with Lung Adenocarcinoma Treated with Definitive Radiation Therapy
    Oro, Federica
    Sonnick, Mark
    Wang, Hongyun
    Zakowski, Maureen
    Wu, Abraham J.
    Chaff, Jamie E.
    Paik, Paul
    Tsang, Mazie
    Hsu, Meier
    Rosenzweig, Kenneth
    Zhang, Zhigang
    Rimner, Andreas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S576 - S576
  • [6] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
    Marks, Jenifer L.
    Broderick, Stephen
    Zhou, Qin
    Chitale, Dhananjay
    Li, Allan R.
    Zakowski, Maureen F.
    Kris, Mark G.
    Rusch, Valerie W.
    Azzoli, Christopher G.
    Seshan, Venkatraman E.
    Ladanyi, Marc
    Pao, William
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 111 - 116
  • [7] EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Marks, Jenifer L.
    Broderick, Stephen
    Seshan, Venkatraman E.
    Zakowski, Maureen F.
    Li, Allan
    Wilson, Richard
    Kris, Mark G.
    Ladanyi, Mark
    Rusch, Valerie W.
    Pao, William
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S481
  • [8] Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Johnson, M. L.
    Sima, C.
    Paik, P. K.
    Janjigian, Y. Y.
    Pao, W.
    Kris, M. G.
    Ladanyi, M.
    Riely, G. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma
    Janjigian, Yelena Y.
    Kris, Mark G.
    Pao, William
    Marks, Jenifer L.
    Zheng, Junting
    Shen, Ronglai
    Dycoco, Joseph P.
    Park, Bernard J.
    Riely, Grey J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S333 - S333
  • [10] Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma.
    D'Angelo, S. P.
    Janjigian, Y. Y.
    Kris, M. G.
    Pao, W.
    Riely, G. J.
    Marks, J.
    Sima, C.
    Dycoco, J.
    Park, B. J.
    Azzoli, C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)